{"disease":{"id":"myocardial-perfusion-imaging","name":"myocardial perfusion imaging"},"drugs":{"marketed":[{"drug_id":"thallous-chloride","indication_name":"Myocardial perfusion imaging","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"THALLOUS CHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"adenosine","indication_name":"Myocardial Perfusion Imaging Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Adenocard","generic_name":"ADENOSINE","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"Adenosine receptor A3","drug_class":"Adenosine Receptor Agonist [EPC]","quality_score":43,"revenue":null,"mechanism":""},{"drug_id":"regadenoson","indication_name":"Myocardial Perfusion Imaging Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Regadenoson","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"A2A adenosine receptor","drug_class":"Adenosine receptor agonist","quality_score":61,"revenue":null,"mechanism":"Regadenoson is a low affinity A2A adenosine receptor agonist that produces coronary vasodilation and increases coronary blood flow."},{"drug_id":"persantin","indication_name":"Myocardial Perfusion Imaging Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Persantin","company_name":"Boehringer Ingelheim","drug_phase":"phase_1","molecular_target":"Equilibrative nucleoside transporter 4, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"ganciclovir","indication_name":"Myocardial Perfusion Imaging Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytovene","generic_name":"GANCICLOVIR","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Metabotropic glutamate receptor 1","drug_class":"Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":80,"revenue":null,"mechanism":"GANCICLOVIR works by inhibiting the DNA polymerase enzyme of cytomegalovirus, preventing viral replication."},{"drug_id":"dipyridamole","indication_name":"Myocardial Perfusion Imaging Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Persantine","generic_name":"DIPYRIDAMOLE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Equilibrative nucleoside transporter 1","drug_class":"Platelet Aggregation Inhibitor [EPC]","quality_score":80,"revenue":null,"mechanism":"Persantine works by inhibiting platelet activation and aggregation by blocking the equilibrative nucleoside transporter 1."},{"drug_id":"adenosin","indication_name":"Myocardial Perfusion Imaging Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Adenosin","company_name":"University of Roma La Sapienza","drug_phase":"marketed","molecular_target":"Phosphatidylinositol 4-kinase type 2-alpha, Phosphatidylinositol 4-kinase type 2-beta, Adenosine kinase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lexiscan","indication_name":"Myocardial Perfusion Imaging Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lexiscan","company_name":"Medical University of South Carolina","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Adenosine receptor A1, Adenosine receptor A2a","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03180060","title":"Meta-Analysis of Stress Myocardial Perfusion Imaging","phase":"","overall_status":"COMPLETED","enrollment_count":23051,"lead_sponsor_name":"American British Cowdray Medical Center","has_results":false},{"nct_id":"NCT04599192","title":"Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT03084562","title":"Regadenoson vs Dipyridamole in Use as Pharmacological Stress Agent Before SPECT","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03150342","title":"Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Far Eastern Memorial Hospital","has_results":false},{"nct_id":"NCT06149195","title":"18F-MFBG Cardiac Imaging for Heart Failure Administration","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Sichuan Provincial People's Hospital","has_results":false},{"nct_id":"NCT03937921","title":"Dotarem Evaluation for Myocardial Perfusion CMR","phase":"","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT04465526","title":"The Influence of Coronary Chronic Total Occlusion on Myocardial Perfusion on Computed Tomography","phase":"","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"National Institute of Cardiology, Warsaw, Poland","has_results":false},{"nct_id":"NCT03173716","title":"Real-Time Myocardial Perfusion Echocardiography in the ICU","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT07187895","title":"Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"Sinotau Pharmaceutical Group","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}